In summary, we proposed a positive feedback loop of THAP9-AS1/miR-133b/SOX4 in the process of ESCC, providing a novel prognostic biomarker and therapeutic target for ESCC patients. This evidence concerns the gene SOX4 and esophageal squamous cell carcinoma.